Before Letybo was approved, there were five neuromodulators available to injectors in the US: Botox, Xeomin, Dysport, Daxxify ...

For more information: www.galderma.com. References Shridharani SM, et al. Efficacy and Safety of RelabotulinumtoxinA, a New Ready-to-Use Liquid Formulation Botulinum Toxin: Results From the READY ...

Over the last 30 years in the neurotoxins market, Ipsen has established itself as one of the leading players in neurosciences, successfully driving research, clinical development and growth based on ...

Galderma will present updates from across its broad dermatology portfolio at the 2025 American Academy of Dermatology (AAD) Annual Meeting, taking place from March 7-11, 2025 in Orlando, Florida ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma will present updates from across its broad dermatology portfolio at the 2025 American Academy of Dermatology (AAD) Annual Meeting, taking place from ...

Shareholders of Galderma Group AG raised about 1.34 billion Swiss francs ($1.5 billion) from the sale of a roughly 6.3% stake in the Swiss skincare group. Buyout group EQT AB, Abu Dhabi Investment ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SWX:GALD): NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE ...